TCM
ABBV icon

Traub Capital Management’s AbbVie ABBV Stock Holding History

Traub Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Hold
1,169
– – 0.26% 92
2026
Q1 		$254K Hold
1,169
– – 0.25% 97
2025
Q4 		$267K Hold
1,169
– – 0.26% 95
2025
Q3 		$271K Hold
1,169
– – 0.27% 94
2025
Q2 		$217K Buy
+1,169
New +$217K 0.2% 105

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Traub Capital Management's ABBV Position: Q2 2026 in Review

Traub Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,169 shares worth $294K. The position accounts for 0.26% of the portfolio, ranked #92.

Traub Capital Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Traub Capital Management held 1,169 shares of AbbVie worth $294K as of Q2 2026.
  • Traub Capital Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.26% of Traub Capital Management's portfolio in Q2 2026, its #92 holding.
  • Traub Capital Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Traub Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.